Positron Corporation (POSC)
USD 1.57
(-16.49%)
USD 1.57
(-16.49%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 734.66 Thousand USD | 0.97% |
| 2022 | 727.58 Thousand USD | -17.5% |
| 2021 | 881.95 Thousand USD | 7.07% |
| 2020 | 823.74 Thousand USD | 5.89% |
| 2019 | 777.95 Thousand USD | -46.19% |
| 2018 | 1.44 Million USD | 0.0% |
| 2014 | 1.46 Million USD | -10.06% |
| 2013 | 1.63 Million USD | -41.81% |
| 2012 | 2.8 Million USD | -57.96% |
| 2011 | 6.66 Million USD | 44.13% |
| 2010 | 4.62 Million USD | 219.71% |
| 2009 | 1.44 Million USD | -31.98% |
| 2008 | 2.12 Million USD | -35.75% |
| 2007 | 3.3 Million USD | 49.53% |
| 2006 | 2.21 Million USD | 190.42% |
| 2005 | 762 Thousand USD | -72.59% |
| 2004 | 2.78 Million USD | -45.15% |
| 2003 | 5.06 Million USD | 8.24% |
| 2002 | 4.68 Million USD | 84.33% |
| 2001 | 2.54 Million USD | -62.22% |
| 2000 | 6.72 Million USD | 339.76% |
| 1999 | 1.52 Million USD | -23.85% |
| 1998 | 2 Million USD | -43.05% |
| 1997 | 3.52 Million USD | -1.37% |
| 1996 | 3.57 Million USD | -32.55% |
| 1995 | 5.3 Million USD | -13.11% |
| 1994 | 6.1 Million USD | 154.17% |
| 1993 | 2.4 Million USD | -63.64% |
| 1992 | 6.6 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 157.75 Thousand USD | -5.77% |
| 2023 Q4 | 167.41 Thousand USD | -7.38% |
| 2023 Q1 | 180.75 Thousand USD | 0.0% |
| 2023 Q3 | 180.75 Thousand USD | -12.15% |
| 2023 FY | 734.66 Thousand USD | 0.97% |
| 2023 Q2 | 205.75 Thousand USD | 13.83% |
| 2022 Q3 | 180.75 Thousand USD | 0.0% |
| 2022 Q1 | 185.33 Thousand USD | -12.86% |
| 2022 FY | 727.58 Thousand USD | -17.5% |
| 2022 Q2 | 180.75 Thousand USD | -2.47% |
| 2022 Q4 | 180.75 Thousand USD | 0.0% |
| 2021 Q4 | 212.69 Thousand USD | -0.07% |
| 2021 Q3 | 212.84 Thousand USD | -13.13% |
| 2021 Q2 | 244.99 Thousand USD | 15.88% |
| 2021 Q1 | 211.42 Thousand USD | 0.0% |
| 2021 FY | 881.95 Thousand USD | 7.07% |
| 2020 FY | 823.74 Thousand USD | 5.89% |
| 2020 Q2 | 196.01 Thousand USD | 0.0% |
| 2019 FY | 777.95 Thousand USD | -46.19% |
| 2018 FY | 1.44 Million USD | 0.0% |
| 2015 Q1 | 346 Thousand USD | 33.59% |
| 2015 Q3 | 304 Thousand USD | -7.32% |
| 2015 Q2 | 328 Thousand USD | -5.2% |
| 2014 Q2 | 355 Thousand USD | -22.15% |
| 2014 FY | 1.46 Million USD | -10.06% |
| 2014 Q4 | 259 Thousand USD | -34.6% |
| 2014 Q3 | 396 Thousand USD | 11.55% |
| 2014 Q1 | 456 Thousand USD | -4.2% |
| 2013 Q1 | 371 Thousand USD | -1.85% |
| 2013 Q2 | 432 Thousand USD | 16.44% |
| 2013 FY | 1.63 Million USD | -41.81% |
| 2013 Q3 | 351 Thousand USD | -18.75% |
| 2013 Q4 | 476 Thousand USD | 35.61% |
| 2012 Q3 | 370 Thousand USD | -69.77% |
| 2012 FY | 2.8 Million USD | -57.96% |
| 2012 Q2 | 1.22 Million USD | 47.65% |
| 2012 Q4 | 378 Thousand USD | 2.16% |
| 2012 Q1 | 829 Thousand USD | 186.85% |
| 2011 Q3 | 482 Thousand USD | -84.05% |
| 2011 FY | 6.66 Million USD | 44.13% |
| 2011 Q4 | 289 Thousand USD | -40.04% |
| 2011 Q2 | 3.02 Million USD | 5.22% |
| 2011 Q1 | 2.87 Million USD | 29.97% |
| 2010 Q1 | 467 Thousand USD | -16.16% |
| 2010 FY | 4.62 Million USD | 219.71% |
| 2010 Q3 | 1.01 Million USD | 8.46% |
| 2010 Q4 | 2.2 Million USD | 118.07% |
| 2010 Q2 | 934 Thousand USD | 100.0% |
| 2009 FY | 1.44 Million USD | -31.98% |
| 2009 Q3 | 188 Thousand USD | -43.71% |
| 2009 Q2 | 334 Thousand USD | -8.99% |
| 2009 Q1 | 367 Thousand USD | -33.15% |
| 2009 Q4 | 557 Thousand USD | 196.28% |
| 2008 Q2 | 767 Thousand USD | 80.05% |
| 2008 Q3 | 384 Thousand USD | -49.93% |
| 2008 Q4 | 549 Thousand USD | 42.97% |
| 2008 Q1 | 426 Thousand USD | -36.32% |
| 2008 FY | 2.12 Million USD | -35.75% |
| 2007 FY | 3.3 Million USD | 49.53% |
| 2007 Q4 | 669 Thousand USD | 17.37% |
| 2007 Q1 | 1.2 Million USD | -9.43% |
| 2007 Q2 | 869 Thousand USD | -27.64% |
| 2007 Q3 | 570 Thousand USD | -34.41% |
| 2006 Q2 | 266 Thousand USD | 34.34% |
| 2006 FY | 2.21 Million USD | 190.42% |
| 2006 Q1 | 198 Thousand USD | -1.0% |
| 2006 Q3 | 423 Thousand USD | 59.02% |
| 2006 Q4 | 1.32 Million USD | 213.48% |
| 2005 FY | 762 Thousand USD | -72.59% |
| 2005 Q4 | 200 Thousand USD | 12.36% |
| 2005 Q2 | 205 Thousand USD | 14.53% |
| 2005 Q3 | 178 Thousand USD | -13.17% |
| 2005 Q1 | 179 Thousand USD | -67.03% |
| 2004 Q1 | 243 Thousand USD | -25.0% |
| 2004 Q3 | 1.75 Million USD | 644.92% |
| 2004 Q4 | 543 Thousand USD | -69.11% |
| 2004 FY | 2.78 Million USD | -45.15% |
| 2004 Q2 | 236 Thousand USD | -2.88% |
| 2003 Q2 | 601 Thousand USD | -84.05% |
| 2003 Q4 | 324 Thousand USD | -13.83% |
| 2003 FY | 5.06 Million USD | 8.24% |
| 2003 Q3 | 376 Thousand USD | -37.44% |
| 2003 Q1 | 3.76 Million USD | 920.87% |
| 2002 Q4 | 369 Thousand USD | 10.81% |
| 2002 Q1 | 1.49 Million USD | 20.45% |
| 2002 Q2 | 2.48 Million USD | 66.04% |
| 2002 Q3 | 333 Thousand USD | -86.59% |
| 2002 FY | 4.68 Million USD | 84.33% |
| 2001 Q1 | 493 Thousand USD | -21.62% |
| 2001 Q4 | 1.24 Million USD | 248.88% |
| 2001 Q2 | 449 Thousand USD | -8.92% |
| 2001 FY | 2.54 Million USD | -62.22% |
| 2001 Q3 | 356 Thousand USD | -20.71% |
| 2000 Q3 | 3.38 Million USD | 119.66% |
| 2000 FY | 6.72 Million USD | 339.76% |
| 2000 Q2 | 1.54 Million USD | 31.82% |
| 2000 Q1 | 1.16 Million USD | 0.0% |
| 2000 Q4 | 629 Thousand USD | -81.42% |
| 1999 FY | 1.52 Million USD | -23.85% |
| 1998 FY | 2 Million USD | -43.05% |
| 1997 Q1 | 600 Thousand USD | 4.35% |
| 1997 FY | 3.52 Million USD | -1.37% |
| 1996 Q3 | 1.3 Million USD | 160.0% |
| 1996 Q4 | 575 Thousand USD | -55.77% |
| 1996 FY | 3.57 Million USD | -32.55% |
| 1996 Q2 | 500 Thousand USD | -58.33% |
| 1996 Q1 | 1.2 Million USD | -14.29% |
| 1995 Q2 | 3 Million USD | 650.0% |
| 1995 Q1 | 400 Thousand USD | -84.0% |
| 1995 Q4 | 1.4 Million USD | 250.0% |
| 1995 Q3 | 400 Thousand USD | -86.67% |
| 1995 FY | 5.3 Million USD | -13.11% |
| 1994 Q2 | 500 Thousand USD | -80.0% |
| 1994 Q1 | 2.5 Million USD | 180.65% |
| 1994 FY | 6.1 Million USD | 154.17% |
| 1994 Q3 | 600 Thousand USD | 20.0% |
| 1994 Q4 | 2.5 Million USD | 316.67% |
| 1993 Q3 | 1.9 Million USD | 5.56% |
| 1993 Q2 | 1.8 Million USD | 0.0% |
| 1993 FY | 2.4 Million USD | -63.64% |
| 1993 Q4 | -3.1 Million USD | -263.16% |
| 1993 Q1 | 1.8 Million USD | 5.88% |
| 1992 Q3 | 1.7 Million USD | 6.25% |
| 1992 Q4 | 1.7 Million USD | 0.0% |
| 1992 FY | 6.6 Million USD | 0.0% |
| 1992 Q1 | 1.6 Million USD | 0.0% |
| 1992 Q2 | 1.6 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 714.7 Thousand USD | -2.792% |
| IR-Med Inc. | - USD | -Infinity% |
| Polarean Imaging plc | 890.93 Thousand USD | 17.54% |
| Medical Supply International USA, Inc. | 2.81 Million USD | 73.924% |
| Avitar, Inc. | 3.1 Million USD | 76.349% |
| AVITA Medical, Inc. | 50.56 Million USD | 98.547% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | 99.906% |
| Zecotek Photonics Inc. | 86.61 Thousand USD | -748.246% |
| QHSLab, Inc. | 1.4 Million USD | 47.859% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | 99.906% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 52.61 Million USD | 98.604% |
| Escalon Medical Corp. | 11.98 Million USD | 93.868% |
| Aurora Spine Corporation | 14.52 Million USD | 94.94% |
| BrainsWay Ltd. | 31.78 Million USD | 97.689% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 257.39 Thousand USD | -185.419% |
| Hamilton Thorne Ltd. | 68.45 Million USD | 98.927% |
| Vivos Inc. | 19.5 Thousand USD | -3667.518% |
| MicroPort Scientific Corporation | 950.72 Million USD | 99.923% |
| Kelyniam Global, Inc. | 2.67 Million USD | 72.509% |
| REMSleep Holdings, Inc. | 203.71 Thousand USD | -260.629% |
| CYduct Diagnostics, Inc. | 84.48 Thousand USD | -769.592% |
| Nanomix Corporation | 15.45 Thousand USD | -4655.12% |
| Theraclion SA | 1.82 Million USD | 59.683% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 661.55 Thousand USD | -11.052% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.34 Million USD | 45.532% |
| Lombard Medical, Inc. | 12.16 Million USD | 93.963% |
| ALR Technologies Inc. | 7468.00 USD | -9737.52% |
| Stratec SE | 289.14 Million USD | 99.746% |
| Vycor Medical, Inc. | 1.46 Million USD | 49.701% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 403.53 Thousand USD | -82.058% |
| SANUWAVE Health, Inc. | 20.39 Million USD | 96.398% |
| VMS Rehab Systems, Inc. | 71.70 USD | -1024538.773% |
| Guided Therapeutics, Inc. | 98 Thousand USD | -649.659% |
| Ingen Technologies, Inc. | 720.67 Thousand USD | -1.941% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 2.84 Million USD | 74.179% |
| Urologix, Inc. | 14.23 Million USD | 94.839% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | 3.3 Million USD | 77.756% |
| SS Innovations International, Inc. | 5.87 Million USD | 87.505% |
| Qualis Innovations, Inc. | 40.17 Thousand USD | -1728.665% |
| Smith & Nephew plc | 5.68 Billion USD | 99.987% |
| NIOX Group Plc | 46.84 Million USD | 98.432% |
| Fuse Medical, Inc. | 16.11 Million USD | 95.441% |
| Broncus Holding Corporation | 10.25 Million USD | 92.836% |
| Brain Scientific Inc. | 214.56 Thousand USD | -242.399% |
| Pressure BioSciences, Inc. | 1.97 Million USD | 62.854% |
| Health Logic Interactive Inc. | - USD | -Infinity% |